Focus on Suicide
ABSTRACT
Background: Most suicides are first attempts that are difficult to predict, possibly reflecting impaired and unstable behavior regulation. We sought to identify characteristics specifically associated with severe suicidal behavior by comparing risk ratios (RRs) for severe suicidal attempts (ATTP) to RRs for suicidal ideation (SI) only in a transdiagnostic sample of Veterans, focusing on impulsive-aggressive or externalizing behavior (EB), substance use disorders (SUDs), and recurrent affective or psychotic disorders (ie, severe mental illness [SMI]).
Methods: The VA Information and Computing Infrastructure (VINCI) Data Navigators provided aggregate phenotype counts and relevant ICD and clinic codes from about 350,000 Veterans in the US Department of Veterans Affairs national Million Veterans Program (MVP). Data were collected by MVP between 2011 and 2017, without relationship to the current work. Work on this report and related analyses took place from April 11, 2020, to October 6, 2021.
Results: We compared 3 suicide risk groups: 1,269 Veterans with previous ATTP, 109,836 with SI only, and 242,872 without previous suicidality. Nearly three-fourths of ATTP Veterans did not have SMI diagnoses. RR for ATTP behavior was highest in Veterans with EB (25.4), followed by those with SUD (13.9); both RRs were greater than RRs for Veterans with schizophrenia (7.4) or bipolar disorder (7.8). ATTP RR was greater for smoking than for major depressive disorder (5.0 vs 3.5, respectively). RR for smoking, across clinical groups, was strongly related to RR for ATTP risk, but not for SI only.
Discussion: ATTP suicidal behavior was more strongly associated with EB and SUD than with SMI. Suicide risk is associated with SUD or EB beyond SMI, so routine clinical encounters in primary care and emergency settings must recognize EB, SUD, and smoking as risks for severe suicidal behavior.
J Clin Psychiatry 2022;83(3):21m14123
To cite: Swann AC, Graham DP, Wilkinson AV, et al. Suicide risk in a national VA sample: roles of psychiatric diagnosis, behavior regulation, substance use, and smoking. J Clin Psychiatry. 2022;83(3):21m14123.
To share: https://doi.org/10.4088/JCP.21m14123
© 2022 Physicians Postgraduate Press, Inc.
aMichael E. DeBakey Veterans Affairs Medical Center, Houston, Texas
bDepartment of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas
cUniversity of Texas Health School of Public Health in Austin and Michael & Susan Dell Center for Healthy Living, Austin, Texas
*Corresponding author: Alan C. Swann, MD, 1977 Butler Blvd, Ste E4.400, Houston, TX 77030 ([email protected]).
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
CME Background
Articles are selected for credit designation based on an assessment of the educational needs of CME participants, with the purpose of providing readers with a curriculum of CME articles on a variety of topics throughout each volume. Activities are planned using a process that links identified needs with desired results.
To obtain credit, read the article, correctly answer the questions in the Posttest, and complete the Evaluation. A $10 processing fee will apply.
CME Objective
After studying this article, you should be able to:
- Screen patients for risk factors for suicide (eg, tobacco smoking and impulsivity) that transcend individual psychiatric disorders
Accreditation Statement
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
The CME Institute of Physicians Postgraduate Press, Inc., designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Release, Expiration, and Review Dates
This educational activity was published in June 2022 and is eligible for AMA PRA Category 1 Credit™ through June 30, 2023. The latest review of this material was May 2022.
Financial Disclosure
All individuals in a position to influence the content of this activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest. The CME Institute has resolved any conflicts of interest that were identified. In the past 3 years, Marlene P. Freeman, MD, Editor in Chief, has received research funding from JayMac and Sage; has been a member of the Independent Data Safety and Monitoring Committee for Janssen (Johnson & Johnson), Novartis, and Neurocrine; and has served on advisory boards for Eliem and Sage. As an employee of Massachusetts General Hospital (MGH), Dr Freeman works with the MGH National Pregnancy Registry, which receives funding from Alkermes, Aurobindo, AuroMedics, Johnson & Johnson/Janssen, Otsuka, Sage, Sunovion, Supernus, and Teva, and works with the MGH Clinical Trials Network and Institute, which receives research funding from multiple pharmaceutical companies and the National Institute of Mental Health. Dr Freeman has also received royalties through MGH for the Massachusetts General Hospital Female Reproductive Lifecycle and Hormones Questionnaire. No member of the CME Institute staff reported any relevant personal financial relationships. Faculty financial disclosure appears at the end of the article.
CHARACTERIZATION AND TIME COURSE OF TRANSDIAGNOSTIC SUICIDE RISK
Suicide, the Leading Cause of Mortality From Injury, Is Difficult to Predict
Suicide is the leading cause of mortality from injury in the United States, exceeding motor vehicle accidents and homicide.1,2 Among medical causes of death, it exceeds diabetes mellitus.3 Suicide among military personnel exceeds combat mortality4 and is the leading cause of non-combat death.5 Yet, identification of effective prevention remains problematic.6,7 Mechanisms underlying suicide risk cross psychiatric diagnoses beyond major affective or psychotic disorders,8–10 making it necessary to look beyond these diagnoses to identify risk-related characteristics that may be missed in non-psychiatric settings. Severe suicide risk can develop rapidly in susceptible people, making prediction difficult.11,12
Levels of Suicide Risk
Because most suicides are first attempts,13–16 susceptibility should ideally be identified before the first attempt.13,14,16 Surviving a medically severe, potentially lethal suicide attempt is a strong predictor of 5-year all-cause mortality from accident, homicide, and other hazardous behavior, which increases 15-fold in men and 9-fold in women, with a 5,402-fold increase in suicide over the general population.15 Risk is highest during the first year17 and persists for over 10 years.18 Post-hospital survival time correlated negatively with trait impulsivity.19 Thus, impulsivity, or immediate action dysregulation, contributes to acute suicide risk.
Since fatal first suicide attempts appear unrelated to any specific psychiatric diagnosis, other risk factors must be identified to prevent the transition from ideation to attempt,13–16 including risk-related problems in potentially high-risk patients who have not received a psychiatric diagnosis.16 As an initial step, we focused on risk factors in the electronic health record (EHR), comparing 3 risk levels: (1) suicide attempts or severe ideation/plan with hospitalizations (ATTP); (2) suicidal ideation (SI) only, and (3) no SI or behavior (SIB).
Rationale
Suicidal behavior disorder in DSM-5–TR crosses diagnoses.8,9 Fatal first suicide attempts (at least 60% of suicides13,16) occur in persons without diagnoses commonly considered to increase suicide risk.16 Instead, suicide may be associated with (1) clinically noted impulsive or aggressive behavior (ie, externalizing behavior [EB]) and (2) substance use disorders (SUDs), including smoking. Because suicide occurs across and beyond conventional psychiatric diagnoses, evaluation of risk requires identification of characteristics that are identifiable in non-psychiatric settings. Rather than focusing on traditional diagnoses and mental health care settings, we investigated relationships between suicide risk and clinical characteristics, with or without apparent psychiatric diagnoses. In a national community sample of 350,000 Veterans, we used EHR20,21 data to identify susceptibility characteristics for suicide.
METHODS
Source Population
About 350,000 Veterans in the US Department of Veterans Affairs (VA) Million Veterans Project (MVP; the population recruited with available data at the time of our analyses) provided EHR data via the VA Information and Computing Infrastructure (VINCI) portal. Using the “Hands-off” approach, VINCI Data Navigators provided cross-tabulations of aggregate phenotype counts, ICD codes, clinic codes, and risk flags (behavioral and suicide).20 ICD-9 codes were converted to ICD-10 codes. Identifying and genetic information was not available to the authors. Characteristics studied included history of suicidal ideation or behavior, smoking, alcohol and other SUD history, impulsive-aggressive behavior, and recurrent affective or psychotic disorders.
The sample was recruited and the data entered and processed by MVP between 2011 and 2017. This article was developed between April 11, 2020, and October 6, 2021.
Identification of Suicide Risk Categories
Preventing transdiagnostic SIB requires high-risk markers accessible in broad, non-psychiatric populations. We defined 3 sets of characteristics from EHR to compare across risk categories: (1) major psychiatric disorders or severe mental illness (SMI) (major depressive disorder, bipolar disorder, or schizophrenia), (2) impulsivity or impulsive aggression disorders (often referred to as EB), and (3) SUD, including smoking. The suicide risk categories were (1) ATTP (n = 1,269) suicide-risk flag plus hospitalization; (2) SI, ie, suicidal ideation without specific plans or attempts (n = 109,836); and (3) no SIB (n = 242,872). We anticipated relatively high specificity for ATTP, but less for the lower-risk SI-only group.21
Characteristics of suicide risk groups. We obtained demographic data from VINCI (characteristics of suicidal behavior groups) and from Radhakrishnan et al22 (characteristics of the overall study sample). ATTP (mean ± SD age, 59.5 ± 9.1 years) or SI (61.3 ± 13 years) were younger than the general available MVP population (65.9 ± 11.7 years).22 A higher percentage of women were in ATTP (19%) or SI (12.7%) groups than in the overall MVP group (7.6%). A higher percentage of African Americans were in the ATTP (22.3%) or SI (23.4%) groups than in the overall MVP group (10.5%).
Definitions of clinical groups. We defined problem drinking as having an Alcohol Use Disorders Identification Test–Consumption (AUDIT-C) score > 323 (n = 113,224) and severe alcohol use as meeting ICD codes for withdrawal or detoxification (F10.23; n = 2,286). Prevalence of addictions was measured by outpatient treatment referral for SUD (n = 56,338), greater than the number with a corresponding SUD diagnosis code. We defined smoking as current cigarette use (n = 49,853).
EB markers were (1) restricted/monitored hospital access because of aggressive or other inappropriate behavior (n = 1,597); (2) ICD code for impulsivity- or aggression-related problems in EHRs, including borderline (F60.3) or antisocial (F60.2) personality disorders, intermittent explosive disorder (F63.81), and unspecified impulsive disorder (F63.9) (n = 3,097); and (3) history of arrest, probation, or incarceration (ICD code Z65.3) (n = 4,203). Overall, 8,146 had 1 marker, 673 had 2, and 72 had all 3. These conditions are probably underdiagnosed, especially in non-psychiatric settings, possibly reducing sensitivity but increasing specificity.
We classified major psychiatric disorders from EHRs, recognizing that potential disadvantages of EHRs7,21,24,25 may be outweighed by their efficiency for studying large samples without additional participant burden of specialized assessments. We used multiple diagnostic codes for each disorder and characteristic21,25,26 because these ICD ranges balanced clinical consistency with local or clinician-related variation and diagnostic instability. The ICD-10 codes used were F20–F29 for schizophrenia, F30 or F31 for bipolar disorder, and F32 or F33 for major depressive disorders.
Statistical Methods
We calculated risk ratios (RRs) rather than odds ratios (ORs) along with confidence intervals (CIs) because large sample sizes distort ORs, overestimating their effects.27 Analyses used STATA 16 (College Station, Texas).
RESULTS
Clinical and Behavioral Characteristics of Suicide Risk
Suicide risk and psychiatric diagnosis. Table 1 shows suicide-related RRs for Veterans with EHR diagnoses of SMI: major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia. For ATTP, 369 (29.1%) of 1,269 had diagnoses of SMI, compared to 15.5% of those with SI. Therefore, about 71% of ATTP did not have an SMI diagnosis. In the ATTP group, those with schizophrenia and BD had RRs significantly greater than those with MDD. Participants with BD had the highest RR for SI. RRs were higher for ATTP than for SI. ATTP RR was substantially lower in the MDD group than in the other groups. Not having one of these diagnoses reduced RR for ATTP and SI to less than 1, suggesting that not having that diagnosis had protective effects against SIB in general.
Externalizing, impulsive-aggressive behavior and suicide risk. Table 2 shows that EBs expressed as impulsive and/or aggressive behavior are related to apparent suicide risk. RRs for ATTP were substantially higher among those with behavioral flags and behavior-related diagnosis than among those with recurrent psychiatric diagnoses (Figure 1). Further, RRs for ATTP were substantially higher than for SI. Veterans with impulsivity-related problems had the largest ATTP RRs (25.4) in the study population. Over three-fourths of the Veterans noted in Table 2 had histories of SI (6,448/8,146); lack of an impulsivity-related diagnosis reduced RR for SIB.
SUD and suicide risk. Table 3 shows that, for alcohol or SUD, RRs were higher for ATTP than for SI. AUDIT-C score > 3 was common in the study sample, present in half with ATTP and about one-third of the overall group with SIB. This threshold score for potential problem drinking23 can lead to suggested referral for evaluation and treatment. History of alcohol withdrawal or need for detoxification increased the RR for ATTP by 4-fold relative to problem drinking. This finding may arise from susceptibility to bouts of out-of-control drinking, which is common immediately before suicide attempts even in those without regular drinking or a diagnosed alcohol use disorder.28,29 Two-thirds of the Veterans in SUD treatment had histories of suicidal ideation; RR for ATTP was 5 times that for SI and almost twice the RR for ATTP in BD or schizophrenia.
Cigarette smoking and suicidal behavior. Table 3 shows RRs for smoking and suicidal behavior. About 14% (49,853) had a smoking-related ICD code. Among smokers, as with those with recurrent psychiatric disorders, RRs were significantly higher for ATTP than for SI; not smoking had a protective effect. In the ATTP group, 45% (574/1,269) were smokers, a rate 3 times greater than that for the entire MVP sample. Over 50% (27,694/49,853) of smokers had SI histories.
Figure 1 contrasts the differences in the strengths of association between smoking RR and the RR for two types of suicidal behaviors (ATTP vs SI only) across MDD, BD, schizophrenia, posttraumatic stress disorder (PTSD), SUD, and EB. The ATTP group shows a strong linear trend by disorder between the RR for smoking and the RR for suicide attempts (r2 of 0.95, P < .001), whereas within the SI group there was no association by disorder (r2 = 0.09, NS). In the overall model, there was a highly significant interaction between RR for smoking and RR for SI vs ATTP (F3,11 = 88.3, P < .001; interaction P < .001). Therefore, in addition to its direct effects on suicidal behavior, smoking increased apparent susceptibility to conditions with high RR for ATTP, without effect on RR for SI.
DISCUSSION
Identifying Risk in General Clinical Settings: Mechanisms and Clinical Features
Suicidality in Veterans was related to SMI, impulsive-aggressive EB, and SUDs, including alcohol abuse and smoking. Notably, about 71% (900/1,269) of the ATTP group did not an SMI diagnosis (Table 1), implicating transdiagnostic mechanisms in suicidality.8,9,16 The ATTP group had high RR for ATTP, suggesting that concurrent or preexisting EBs or SUDs are likely to increase suicide risk in Veterans with SMI.
Community- or medical system–based practices can assess these SUD and EB risk factors in EHRs.22 Problems related to EB had the strongest relationship to suicide risk (Table 2). EBs are typically underreported, but clearly merit more careful consideration and screening in primary care settings. The EHR provides indirect measures of behavior regulation; more validated, clinically feasible, direct measures of these EBs are needed.
Neurobehavioral Mechanisms Potentially Underlying Suicide Risk and Behavior
Suicidal behavior links long-term sensitization to addictive or other sensitizing stimuli and immediate impulsive behavior dysregulation.30,31 Table 1 shows that nearly three-fourths of the ATTP sample did not have schizophrenia or a major affective disorder, though suicidality is strongly associated with impulsivity.10 Table 2 and Table 3 show that risk for suicide was strongly related to EB and SUD. Effects of smoking as an SUD on suicidality may be enhanced by prominent roles of nicotinic brain receptors in impulsivity and sensitization related to other stimuli,32–36 as discussed later in this section.
Persistent effects on immediate behavior: sensitization and SUD. In susceptible individuals, highly stressful or rewarding stimuli produce behavioral sensitization and cross-sensitization, disrupting regulation of reward, arousal, and action.31 Sensitization combines anhedonia and impulsivity and predisposes to addictive and suicidal behavior.35–37 Table 3 shows that high risk for suicide was strongly related to SUD. Further, suicide risk had a dose-response relationship to the severity of alcohol problems with substantially higher risk for alcoholism with severe complications than for problem drinking (AUDIT-C score > 3) (Table 3). Smoking increased severe suicide risk independently, but also was increased in the Veterans with SMI and other SUDs, which additively increase risk. Nicotine directly and indirectly increases sensitization38,39: in addition to being a sensitizing stimulus, nicotinic activation is required for sensitization to other stimuli,39,40 consistent with the relationships between RRs for smoking and severe suicidal behavior noted in Figure 1. However, sensitization is not due to nicotinic mechanisms alone, and it requires other factors including dopaminergic D2,41 noradrenergic α1,41 and glutamatergic42 activation. Thus, medicines that reduce sensitization would potentially prevent smoking and suicide.
Development of SUD may require behavioral sensitization.43,44 Cross-sensitization occurs across SUD substances45; for example, early onset of smoking and alcohol use together is strongly associated,46 and alcohol dependence and smoking each increases the likelihood of the other by about 4-fold.33 Cross-sensitization also occurs between SUD and stress-related stimuli37 as shown in humans with PTSD-inducing stressors.47 Susceptibility to sensitization varies widely across individuals, potentially modifying behavior, comorbidities, and illness, but developing SMI does not appear to require sensitization.48,49 Apparent sensitization from coexisting SUD, previous trauma, or many previous suicide attempts is associated with increased risk for suicidal behavior in bipolar disorder and across diagnoses.13,32,33 Therefore, suicide risk in Veterans with SMI may be related to coexisting sensitization-related disorders such as SUD or EB22,33 (Table 3).
Smoking may promote sensitization directly and indirectly. Smoking, a common SUD, has a transdiagnostic effect on suicide risk (Table 3) and a strong association with EB for ATTP (Figure 1). Figure 1 further shows that RRs between clinical groups and smoking correlated strongly for ATTP (r2 = 0.95) but not for SI (r2 = 0.09), with a highly significant interaction between smoking and suicide risk for the ATTP group (P < .001). Nicotine-related mechanisms may, therefore, interact with other characteristics to specifically increase RR for ATTP suicidal behavior across a range of clinical conditions. These two strong associations for smoking may reflect an underlying disruption of action regulation that is increased because smoking delivers nicotine rapidly to the brain.13,17–19,34–37 Nicotine inhalation through vaping also delivers nicotine rapidly to the brain and increases suicidal behavior and attempts, perhaps especially in adolescents.50 Adolescent nicotine use predicts adult suicide.51 Retrospective52,53 and prospective54–57 studies in large non-psychiatric populations, including Veterans and non-Veterans, show that smoking is associated with increased suicide. Greater smoking severity increases suicide risk, regardless of diagnosis and adjusted for demographic and health characteristics.9,52–57 This association suggests involvement of nicotine in transdiagnostic mechanisms of risk. A meta-analysis58 based on a sample of 1.4 million adults reported increased suicide rates by 24% for each 10 cigarettes smoked daily (RR = 1.24; 95% CI, 1.20–1.28). A more recent meta-analysis59 showed that ORs for smoking and suicide increased progressively from ideation to attempt to death. People at high risk of suicide also have increased mortality from accidental injuries; death from injury is greater in heavier than in lighter smokers, independent of age, race, gender, alcohol use, seat belt use, education, and marital status.58 Smoking also predicts suicide risk in patients with major depressive60 and bipolar61 disorders. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC; n = 34,653), a national American adult survey, found that lifetime and past-year nicotine dependence was associated with lifetime and past-year suicide attempts, regardless of diagnoses.62 Suicide risk was lower in nicotine-dependent people who had quit than in current smokers.62
Immediate regulation: impulsivity. Table 2 shows that the strongest predictors of risk were EBs. Impulsivity as manifested in EB results from an imbalance between facilitation and inhibition of action36 and predisposes to suicide.33,36 Trait impulsivity predisposes to behavioral sensitization,31 increasing addiction risk. Impulsivity-related noradrenergic hyper-functioning36,63 impairs prefrontal cortex inhibitory protections against suicide.63,64 Action-impulsivity, with impaired regulation of behavioral inhibition, occurring before conscious awareness,65 predisposes to suicidal and other ATTP-related behavior.31,66
Two aspects of impulsivity are especially relevant to suicide: (1) “Impulsive” versus “planned” attempts is a false dichotomy. Impulsivity is integral to suicidal behavior, but its role and interactions with other characteristics vary.31 Trait impulsivity is higher with both a suicide plan and an attempt than with an attempt or plan alone.67 Momentary impulsivity can make someone more likely to act on a previously formulated plan.11,12,65,66 (2) People are generally not impulsive all the time. Impulsivity appears in susceptible individuals11,12 as a latent trait, elicited by overstimulation or stressors and facilitated by behavioral sensitization.31
Combined impulsivity and hopelessness in ATTP behavior. Impulsivity combined with hopelessness may predict overt suicidal behavior more than either alone.68,69 Impulsive individuals can experience hopelessness, dissociated from depressed mood, predisposing to suicidality.31,69–71 State-dependent impulsivity combined with stress or depressive symptoms can produce negative urgency,35,71–73 combining impulsivity and anhedonia across diagnoses and linking smoking to suicide.65,74 Smoking increases stress-induced risk-taking; cumulative stressors can combine with nicotine-facilitated sensitization and exacerbate suicide risk,32 perhaps especially in those already predisposed to impulsivity or negative urgency (Figure 1).
Limitations and Future Study Implications
Our study has several limitations. (1) RRs were not adjusted for specific demographic characteristics due to the deidentified nature of the database. (2) Clinical psychiatric rating scales, formal diagnostic interviews and details of suicide-related attempts, plans, and hospitalizations were not available for the sample. However, presence of suicide risk flags or hospitalizations increased our sensitivity for severe disturbances. (3) We could not directly assess interactions across risk factors. (4) This EHR-based study had variations in record-keeping across facilities and underdiagnosis or underrecognition of relevant disorders and problems. (5) The time covered by EHRs varied widely over the sample, with little information about relative timing of events, but we used EHRs to identify trait-like measures, reducing the importance of apparent time courses in the EHR. (6) The “SI” group was large and may have overestimated the number of Veterans with sustained or serious rather than transient SI. (7) While Figure 1 demonstrates a strong potential relationship between smoking and disorders specifically associated with high suicide risk, it is likely that the disorder groups overlapped, though this would not alter the direction of these relationships. In summary, this routinely available clinical information provided pragmatic access to a large and generalizable sample, minimizing participant burden and enabling feasible data collection.24
Conclusions
Recognizing SUD and EB could improve identification of Veterans and other community members at risk for attempting and committing suicide and improve design of effective early interventions. Overall, suicide may be more strongly related to SUD or EB than to SMI, and we suggest an important role of transdiagnostic mechanisms of sensitization and impulsivity,31 possibly modeled by smoking effects,30 as targets for suicide prevention.
We suggest two main clinical implications. (1) Patients should be screened efficiently for impulsive behaviors (ie, EB) and SUD, including sporadic bouts of binge substance use. (2) Nicotine-related interactions with cholinergic, noradrenergic and glutamatergic systems may be a neurobiological model for suicide risk38,39,41 offering novel pharmacologic or psychotherapeutic targets.
Submitted: June 6, 2021; accepted December 29, 2021.
Published online: June 6, 2022.
Disclosure of off-label usage: Dr Swann has determined that, to the best of his knowledge, lithium, divalproex, carbamazepine, ketamine, and clozapine are not approved by the US Food and Drug Administration for the treatment of suicide prevention, aggression, or impulsivity.
Relevant financial relationships: The authors have no potential conflicts of interest relative to this work.
Funding/support: Dr Swann received support from the Linda and John Griffin Endowment, Houston, Texas.
Role of the sponsor: The Linda and John Griffin Endowment had no role in the conduct of the study or publication of the results.
Previous presentation: Data from this article were presented (as virtual presentations) at the 2021 Meetings of the Society for Biological Psychiatry (April 28–May 1, 2021) and the International Association for Suicide Research-American Foundation for Suicide Research (October 26, 2021).
Acknowledgments: The authors thank the Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, for facilities and support for this research and the Million Veterans Program, CSRD, for access to relevant data.
CLINICAL POINTS
- Three-quarters of people with high risk for suicide attempts do not have diagnoses of schizophrenia or recurrent affective disorders, and their suicide risks are more strongly associated with addictive and behavioral disorders.
- Since suicide attempts are strongly related to tobacco smoking and impulsivity, smoking cessation and impulsivity screening should become part of primary care suicide prevention programs.
References (74)
- Hedegaard H, Curtin SC, Warner M. Increase in suicide mortality in the United States, 1999–2018. NCHS Data Brief. 2020;362(362):1–8. PubMed
- Rockett IR, Regier MD, Kapusta ND, et al. Leading causes of unintentional and intentional injury mortality: United States, 2000–2009. Am J Public Health. 2012;102(11):e84–e92. PubMed CrossRef
- Rockett IRH, Caine ED, Connery HS, et al. Mortality in the United States from self-injury surpasses diabetes: a prevention imperative. Inj Prev. 2019;25(4):331–333. PubMed CrossRef
- Thompson M, Gibbs N. More U.S. soldiers have killed themselves than have died in the Afghan war: why can’t the Army win the war on suicide? Time. 2012;180(4):22–31. PubMed
- Armed Forces Health Surveillance Center (AFHSC). Deaths while on active duty in the US Armed Forces, 1990–2011. MSMR. 2012;19(5):2–5. PubMed
- Armed Forces Health Surveillance Center (AFHSC). Deaths by suicide while on active duty, active and reserve components, US Armed Forces, 1998–2011. MSMR. 2012;19(6):7–10. PubMed
- Sall J, Brenner L, Millikan Bell AM, et al. Assessment and management of patients at risk for suicide: synopsis of the 2019 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guidelines. Ann Intern Med. 2019;171(5):343–353. PubMed CrossRef
- Oquendo MA, Baca-Garcia E. Suicidal behavior disorder as a diagnostic entity in the DSM-5 classification system: advantages outweigh limitations. World Psychiatry. 2014;13(2):128–130. PubMed
- Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153–160. PubMed CrossRef
- Mann JJ, Arango VA, Avenevoli S, et al. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry. 2009;65(7):556–563. PubMed CrossRef
- Wortzel HS, Homaifar B, Matarazzo B, et al. Therapeutic risk management of the suicidal patient: stratifying risk in terms of severity and temporality. J Psychiatr Pract. 2014;20(1):63–67. PubMed CrossRef
- Barredo J, Bozzay ML, Primack JM, et al. Translating interventional neuroscience to suicide: it’s about time. Biol Psychiatry. 2021;89(11):1073–1083. PubMed CrossRef
- Bostwick JM, Pabbati C, Geske JR, et al. Suicide attempt as a risk factor for completed suicide: even more lethal than we knew. Am J Psychiatry. 2016;173(11):1094–1100. PubMed CrossRef
- Klonsky ED, May AM. Differentiating suicide attempters from suicide ideators: a critical frontier for suicidology research. Suicide Life Threat Behav. 2014;44(1):1–5. PubMed CrossRef
- Beck AT, Brown GK, Steer RA, et al. Suicide ideation at its worst point: a predictor of eventual suicide in psychiatric outpatients. Suicide Life Threat Behav. 1999;29(1):1–9. PubMed
- Jordan JT, McNiel DE. Characteristics of persons who die on their first suicide attempt: results from the National Violent Death Reporting System. Psychol Med. 2020;50(8):1390–1397. PubMed CrossRef
- Ostamo A, Lönnqvist J. Excess mortality of suicide attempters. Soc Psychiatry Psychiatr Epidemiol. 2001;36(1):29–35. PubMed CrossRef
- Suokas J, Suominen K, Isometsä E, et al. Long-term risk factors for suicide mortality after attempted suicide: findings of a 14-year follow-up study. Acta Psychiatr Scand. 2001;104(2):117–121. PubMed CrossRef
- Nordström P, Gustavsson P, Edman G, et al. Temperamental vulnerability and suicide risk after attempted suicide. Suicide Life Threat Behav. 1996;26(4):380–394. PubMed
- Gaziano JM, Concato J, Brophy M, et al. Million Veteran Program: a mega-biobank to study genetic influences on health and disease. J Clin Epidemiol. 2016;70(2):214–223. PubMed CrossRef
- Kim HM, Smith EG, Stano CM, et al. Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use. BMC Health Serv Res. 2012;12(1):18. PubMed CrossRef
- Radhakrishnan K, Aslan M, Harrington KM, et al. Genomics of posttraumatic stress disorder in veterans: methods and rationale for Veterans Affairs Cooperative Study #575B. Int J Methods Psychiatr Res. 2019;28(1):e1767. PubMed CrossRef
- Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res. 2007;31(2):185–199. PubMed CrossRef
- Song W, Kossowsky J, Torous J, et al. Genome-wide association analysis of opioid use disorder: a novel approach using clinical data. Drug Alcohol Depend. 2020;217:108276. PubMed
- Hoffmire C, Stephens B, Morley S, et al. VA Suicide Prevention Applications Network: a national health care system-based suicide event tracking system. Public Health Rep. 2016;131(6):816–821. PubMed CrossRef
- Chen YR, Swann AC, Johnson BA. Stability of diagnosis in bipolar disorder. J Nerv Ment Dis. 1998;186(1):17–23. PubMed CrossRef
- Holmberg MJ, Andersen LW. Estimating risk ratios and risk differences: alternatives to odds ratios. JAMA. 2020;324(11):1098–1099. PubMed CrossRef
- Powell KE, Kresnow M-J, Mercy JA, et al. Alcohol consumption and nearly lethal suicide attempts. Suicide Life Threat Behav. 2001;32(suppl):30–41. PubMed CrossRef
- Peterson LG, Peterson M, O’Shanick G, et al. Self-inflicted gunshot wounds: lethality of method versus intent. Am J Psychiatry. 1985;142:228–231. PubMed
- Swann AC, Graham DP, Wilkinson AV, et al. Nicotine inhalation and suicide: clinical correlates and behavioral mechanisms. Am J Addict. 2021;30(4):316–329. PubMed CrossRef
- Lijffijt M, O’Brien B, Salas R, et al. Interactions of immediate and long-term action regulation in the course and complications of bipolar disorder. Philos Trans R Soc Lond B Biol Sci. 2019;374(1766):20180132. PubMed CrossRef
- Samaha A-N, Yau W-YW, Yang P, et al. Rapid delivery of nicotine promotes behavioral sensitization and alters its neurobiological impact. Biol Psychiatry. 2005;57(4):351–360. PubMed CrossRef
- Moallem NR, Ray LA. Dimensions of impulsivity among heavy drinkers, smokers, and heavy drinking smokers: singular and combined effects. Addict Behav. 2012;37(7):871–874. PubMed CrossRef
- Fields S, Leraas K, Collins C, et al. Delay discounting as a mediator of the relationship between perceived stress and cigarette smoking status in adolescents. Behav Pharmacol. 2009;20(5-6):455–460. PubMed CrossRef
- Doran N, Spring B, McChargue D, et al. Impulsivity and smoking relapse. Nicotine Tob Res. 2004;6(4):641–647. PubMed CrossRef
- Arnsten AF, Mathew R, Ubriani R, et al. Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol Psychiatry. 1999;45(1):26–31. PubMed CrossRef
- Miczek KA, Nikulina E, Kream RM, et al. Behavioral sensitization to cocaine after a brief social defeat stress: c-fos expression in the PAG. Psychopharmacology (Berl). 1999;141(3):225–234. PubMed CrossRef
- DiFranza JR, Wellman RJ. Sensitization to nicotine: how the animal literature might inform future human research. Nicotine Tob Res. 2007;9(1):9–20. PubMed CrossRef
- Mao D, McGehee DS. Nicotine and behavioral sensitization. J Mol Neurosci. 2010;40(1–2):154–163. PubMed CrossRef
- Schoffelmeer AN, De Vries TJ, Wardeh G, et al. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J Neurosci. 2002;22(8):3269–3276. PubMed CrossRef
- Alttoa A, Eller M, Herm L, et al. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus. Brain Res. 2007;1131(1):138–148. PubMed CrossRef
- Wolf ME. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol. 1998;54(6):679–720. PubMed CrossRef
- Le Dorze C, Tassin JP, Chauveau F, et al. Behavioral and noradrenergic sensitizations in vulnerable traumatized rats suggest common bases with substance-use disorders. Mol Neurobiol. 2019;56(1):611–620. PubMed CrossRef
- Lijffijt M, Green CE, Balderston N, et al. A proof-of mechanism study to test effects of the NMDA receptor antagonist lanicemine on behavioral sensitization in individuals with symptoms of PTSD. Front Psychiatry. 2019;10:846. PubMed CrossRef
- Wilkinson AV, Shete S, Spitz MR, et al. Sensation seeking, risk behaviors, and alcohol consumption among Mexican origin youth. J Adolesc Health. 2011;48(1):65–72. PubMed CrossRef
- Lijffijt M, Hu K, Swann AC. Stress modulates illness-course of substance use disorders: a translational review. Front Psychiatry. 2014;5:83. PubMed CrossRef
- Booij L, Welfeld K, Leyton M, et al. Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers. Transl Psychiatry. 2016;6(2):e740. PubMed CrossRef
- Post RM. Epigenetic basis of sensitization to stress, affective episodes, and stimulants: implications for illness progression and prevention. Bipolar Disord. 2016;18(4):315–324. PubMed CrossRef
- Swann AC, Lijffijt M, Lane SD, et al. Severity of bipolar disorder is associated with impairment of response inhibition. J Affect Disord. 2009;116(1–2):30–36. PubMed CrossRef
- Kim SH, Jeong SH, Park E-C, et al. Association of cigarette type initially smoked with suicidal behaviors among adolescents in Korea from 2015 to 2018. JAMA Netw Open. 2021;4(4):e218803. PubMed CrossRef
- Riala K, Alaräisänen A, Taanila A, et al. Regular daily smoking among 14-year-old adolescents increases the subsequent risk for suicide: the Northern Finland 1966 Birth Cohort Study. J Clin Psychiatry. 2007;68(5):775–780. PubMed CrossRef
- Balbuena L, Tempier R. Independent association of chronic smoking and abstinence with suicide. Psychiatr Serv. 2015;66(2):186–192. PubMed CrossRef
- Iwasaki M, Akechi T, Uchitomi Y, et al; Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Disease (JPHC study) Group. Cigarette smoking and completed suicide among middle-aged men: a population-based cohort study in Japan. Ann Epidemiol. 2005;15(4):286–292. PubMed CrossRef
- Miller M, Hemenway D, Bell NS, et al. Cigarette smoking and suicide: a prospective study of 300,000 male active-duty Army soldiers. Am J Epidemiol. 2000;151(11):1060–1063. PubMed CrossRef
- Lucas M, O’Reilly EJ, Mirzaei F, et al. Cigarette smoking and completed suicide: results from 3 prospective cohorts of American adults. J Affect Disord. 2013;151(3):1053–1058. PubMed CrossRef
- Miller M, Hemenway D, Rimm E. Cigarettes and suicide: a prospective study of 50,000 men. Am J Public Health. 2000;90(5):768–773. PubMed CrossRef
- Tanskanen A, Tuomilehto J, Viinamäki H, et al. Smoking and the risk of suicide. Acta Psychiatr Scand. 2000;101(3):243–245. PubMed CrossRef
- Li D, Yang X, Ge Z, et al. Cigarette smoking and risk of completed suicide: a meta-analysis of prospective cohort studies. J Psychiatr Res. 2012;46(10):1257–1266. PubMed CrossRef
- Poorolajal J, Darvishi N. Smoking and suicide: a meta-analysis. PLoS One. 2016;11(7):e0156348. PubMed
- Oquendo MA, Galfalvy H, Russo S, et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry. 2004;161(8):1433–1441. PubMed CrossRef
- Ostacher MJ, Lebeau RT, Perlis RH, et al. Cigarette smoking is associated with suicidality in bipolar disorder. Bipolar Disord. 2009;11(7):766–771. PubMed CrossRef
- Yaworski D, Robinson J, Sareen J, et al. The relation between nicotine dependence and suicide attempts in the general population. Can J Psychiatry. 2011;56(3):161–170. PubMed CrossRef
- Arnsten AF, Li BM. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry. 2005;57(11):1377–1384. PubMed CrossRef
- Swann AC, Lijffijt M, Lane SD, et al. Norepinephrine and impulsivity: effects of acute yohimbine. Psychopharmacology (Berl). 2013;229(1):83–94. PubMed CrossRef
- Swann AC, Bjork JM, Moeller FG, et al. Two models of impulsivity: relationship to personality traits and psychopathology. Biol Psychiatry. 2002;51(12):988–994. PubMed CrossRef
- Swann AC, Dougherty DM, Pazzaglia PJ, et al. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry. 2005;162(9):1680–1687. PubMed CrossRef
- Witte TK, Merrill KA, Stellrecht NE, et al. “Impulsive” youth suicide attempters are not necessarily all that impulsive. J Affect Disord. 2008;107(1–3):107–116. PubMed CrossRef
- Barratt ES, Patton JH. Impulsivity: Cognitive, Behavioral, and Psychophysiological Correlates. Zuckerman M, ed. Biological Basis of Sensation-Seeking, Impulsivity, and Anxiety. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1983:77–116.
- Swann AC, Steinberg JL, Lijffijt M, et al. Impulsivity: differential relationship to depression and mania in bipolar disorder. J Affect Disord. 2008;106(3):241–248. PubMed CrossRef
- Simon OR, Swann AC, Powell KE, et al. Characteristics of impulsive suicide attempts and attempters. Suicide Life Threat Behav. 2001;32(suppl):49–59. PubMed CrossRef
- Doran N, Trim RS. The prospective effects of impulsivity on alcohol and tobacco use in a college sample. J Psychoactive Drugs. 2013;45(5):379–385. PubMed CrossRef
- Guillot CR, Pang RD, Leventhal AM. Anxiety sensitivity and negative urgency: a pathway to negative reinforcement-related smoking expectancies. J Addict Med. 2014;8(3):189–194. PubMed CrossRef
- Borges AM, Leyro TM, Rosen RL, et al. Negative urgency and ad-libitum smoking topography. Drug Alcohol Depend. 2019;201:220–226. PubMed CrossRef
- de Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol. 2009;14(1):22–31. PubMed CrossRef
Save
Cite
Advertisement
GAM ID: sidebar-top